DNA test often best for triage of cervical cancer risk

Abnormal Pap results usually should be followed up with a DNA-based test rather than with another cervical smear, a study indicates.

AACR: Two new treatments promising for advanced ovarian cancer

A two-step immunotherapy approach and the experimental antibody-drug conjugate DMUC5754A show promise for advanced ovarian cancer, according to research presented at AACR 2013.

Hormone therapy with estrogen plus progestin ups breast cancer risk

Breast cancer risk highest risk among women who initiate hormone treatment closer to menopause.

HPV genotyping streamlines colposcopy referral

The best HPV screening programs maximize high-grade lesion detection without excessive testing.

Shift work increases womens' risk for ovarian cancer

Shift work may be associated with an increased risk of ovarian cancer, according to a study published in the April issue of Occupational & Environmental Medicine.

New Pap guidelines may delay adenocarcinoma diagnosis

Revisions to cervical cancer protocols may hinder clinicians diagnosing younger women with AIS

SOG: Intraperitoneal chemotherapy improves advanced ovarian cancer survival

IP chemo improves long-term survival in advanced disease versus intravenous therapy

Lynch-related endometrial cancer raises risk of other cancers

Women with Lynch syndrome and endometrial cancer have elevated risks for several other cancers, including breast, bladder, and kidney cancers.

Clinical Trial: Ultrasound Hyperthermia Therapy After Implant Radiation Therapy in Treating Patients With Urinary Tract Cancer, Gynecologic Cancer, or Head and Neck Cancer

Clinical Trial: Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Clinical Trial: Pelvic Exenteration for Gynecologic Malignancy